Targeting IL-6 trans-signalling: past, present and future prospects
Stefan Rose‐John(Christian-Albrechts-Universität zu Kiel), Jürgen Scheller(Heinrich Heine University Düsseldorf)
Cited by 453
Related Papers
Interleukin-6 Family Cytokines
|Cold Spring Harbor Perspectives in Biology|2017|784
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
|Journal of Clinical Investigation|2011|677
Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
|The Journal of Experimental Medicine|2010|273
Inhibition of Classic Signaling Is a Novel Function of Soluble Glycoprotein 130 (sgp130), Which Is Controlled by the Ratio of Interleukin 6 and Soluble Interleukin 6 Receptor
|Journal of Biological Chemistry|2011|206
ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling
|The Journal of Experimental Medicine|2018|77